期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | ENDOCRINE PATHOLOGY LetPub Score 6.2
50 ratings
Rate
Reputation 7.5 Influence 4.9 Speed 7.0 | ||||||||||||||||||||||||
期刊簡稱 | ENDOCR PATHOL | ||||||||||||||||||||||||
ISSN | 1046-3976 | ||||||||||||||||||||||||
E-ISSN | 1559-0097 | ||||||||||||||||||||||||
h-index | 42 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 12.40%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | https://www.springer.com/12022 | ||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/enpa | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | Springer US | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||||||
發行頻率 | 四半期刊行 | ||||||||||||||||||||||||
創刊年 | 1990 | ||||||||||||||||||||||||
每年文章數 | 37每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 31.30% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1046-3976%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: >12 Week(s), or Invited contributions | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Moderate | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[ENDOCRINE PATHOLOGY] 的評論 | 撰寫評論 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 18:56:26 評論於 Choose the journal of the same publisher that you want to switch to, and submit your manuscript according to the submission guidelines of that journal(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 13:47:18 評論於 The corresponding author of an SCI journal paper may not necessarily be only one person, and there is no fixed standard for how many there can be. This is because different SCI journals have different policies regarding the number of corresponding authors. For SCI journals that only accept one corresponding author, if a paper has multiple corresponding authors, the first corresponding author listed will be automatically selected as the corresponding author. For SCI journals that accept two corresponding authors, two corresponding authors can be listed. The same applies to other requirements. That is, the number of authors listed as corresponding authors should comply with the regulations of the target SCI journal. The first author of an SCI paper is the person who has made the greatest contribution to the experiment and writing of the article, and is the person who appears first in the list of authors. However, in collaborations with multiple authors, it is common to have joint first authors. There is no clear definition of the number of joint first authors, and it is closely related to the workload, length of the paper, regulations of the publication, and recognition by institutions. Generally, it is common for an SCI paper to have 2-4 first authors(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 八坂篷蔚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 20:46:05 評論於 How many corresponding authors can there be at most? How many first authors can there be at most?(0) 讚! | 八坂篷蔚 |
作者: Oswald Edie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 08:28:04 評論於 How to transfer between different journals of the same publishing company?(0) 讚! | Oswald Edie |
作者: 无极华藏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-07-08 09:21:17 評論於 Does this magazine charge a layout fee?(0) 讚! | 无极华藏 |
作者: 北陆瀚漠 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-08-16 16:08:51 評論於 Hello, how are you?(0) 讚! | 北陆瀚漠 |
作者: Troy Berkeley 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-03-14 17:45:50 評論於 Reject, but efficient(0) 讚! | Troy Berkeley |
作者: Troy Berkeley 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-03-08 21:12:02 評論於 Submission under review for one week(0) 讚! | Troy Berkeley |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us